This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Examine the effect or oral micronized progesterone (OMP; Prometrium) on seizure frequency in women with catamenial epilepsy who experience perimenstrual seizure exacerbations. Examine the relationship among serum progesterone levels, cognition, seizure frequency and mood in women treated with OMP.
Showing the most recent 10 out of 1825 publications